Umbilical Cord Stem Cell-Derived Exosome Solution "Procentan"
(1) Treatment content: Administer stem cell-derived exosomes to patients via inhalation, application, subcutaneous injection, intravenous injection, intramuscular injection, etc., expecting various effects.
(2) Prescribable drugs and fees: Stem cell conditioned culture medium (Fee: 280,000 yen for a box of 10)
(3) Main side effects and risks: Rare minor symptoms such as itching, rash, mild fever, and allergic reactions may occur.
(4) Indication that it is an unapproved drug, etc.: This drug is an unapproved drug in Japan and is prescribed at the patient's expense. * Unapproved drugs are not covered by public relief systems (Pharmaceutical Side Effect Relief System, Biological Product Infection Relief System). Please be aware of this in advance.
(5) Availability of domestic approved drugs with the same ingredients and efficacy: None
(6) Disclosure of safety information in foreign countries: According to the safety of exosome therapy, no major adverse events have been reported.
Stem Cell Administration Therapy (Intravenous & Subcutaneous)
(1) Treatment content: Cultivate autologous stem cells in-house and administer to patients via intravenous injection, subcutaneous injection, intramuscular injection, intra-articular injection, etc., expecting tissue regeneration effects.
(2) Prescribable drugs and fees: Stem cells (fees vary depending on the number of cells)
(3) Main side effects and risks: Rare minor symptoms such as itching, rash, mild fever, and allergic reactions may occur.
(4) Indication that it is an unapproved drug, etc.: This treatment uses unapproved drugs in Japan and is prescribed at the patient's expense. * Unapproved drugs are not covered by public relief systems (Pharmaceutical Side Effect Relief System, Biological Product Infection Relief System). Please be aware of this in advance.
(5) Availability of domestic approved drugs with the same ingredients and efficacy: None
(6) Disclosure of safety information in foreign countries: According to the safety of stem cell therapy, no major adverse events have been reported.
Stem Cell Administration Therapy (Intra-articular)
(1) Treatment content: Cultivate autologous stem cells in-house and administer to patients via intra-articular injection, etc., expecting tissue regeneration effects in the joints.
(2) Prescribable drugs and fees: Stem cells (fees vary depending on the number of cells)
(3) Main side effects and risks: Rare minor symptoms such as itching, rash, mild fever, and allergic reactions may occur.
(4) Indication that it is an unapproved drug, etc.: This treatment uses unapproved drugs in Japan and is prescribed at the patient's expense. * Unapproved drugs are not covered by public relief systems (Pharmaceutical Side Effect Relief System, Biological Product Infection Relief System). Please be aware of this in advance.
(5) Availability of domestic approved drugs with the same ingredients and efficacy: None
(6) Disclosure of safety information in foreign countries: According to the safety of stem cell therapy, no major adverse events have been reported.
Stem Cell Administration Therapy (Periodontal Disease)
(1) Treatment content: Cultivate autologous stem cells in-house and administer to patients via gingival injection, etc., expecting surrounding tissue regeneration effects.
(2) Prescribable drugs and fees: Stem cells (fees vary depending on the number of cells)
(3) Main side effects and risks: Rare minor symptoms such as itching, rash, mild fever, and allergic reactions may occur.
(4) Indication that it is an unapproved drug, etc.: This treatment uses unapproved drugs in Japan and is prescribed at the patient's expense. * Unapproved drugs are not covered by public relief systems (Pharmaceutical Side Effect Relief System, Biological Product Infection Relief System). Please be aware of this in advance.
(5) Availability of domestic approved drugs with the same ingredients and efficacy: None
(6) Disclosure of safety information in foreign countries: According to the safety of stem cell therapy, no major adverse events have been reported.
Medical Advertising Guidelines
At Indiba Clinic, in response to the medical advertising guidelines that came into effect on June 1, 2018, we have removed testimonials from our website. Additionally, when posting case photos, we have revised the website to display explanations of procedures, risks, and prices. We apologize for any inconvenience this may cause to our patients and customers, and thank you for your understanding.
Excerpt from the Original Medical Advertising Guidelines
Article 1: Purpose of Advertising Regulations
Regarding partial amendments to the Medical Care Act
If the advertising restrictions are extended to include websites of medical institutions, limiting the scope of advertising may hinder the smooth provision of detailed medical information that patients seek. Therefore, under certain conditions, the restriction on advertising content is lifted.
Article 3: Prohibited Advertisements
(5) Testimonials based on the subjective views of patients or others regarding the content or effects of treatment
"Advertisements based on testimonials of patients or others," as stipulated in Article 1, Section 9, Paragraph 1 of the Ordinance, refers to the introduction of subjective testimonials based on the experiences of patients themselves or hearsay from family members to attract patients to the medical institution. Since these testimonials naturally vary depending on the patient's condition, they may cause misunderstanding and are not permitted as medical advertisements.
(6) Photos, etc. of treatment results that may mislead patients
"Advertisements of photos, etc. of treatment results that may mislead patients," as stipulated in Article 1, Section 9, Paragraph 2 of the Ordinance, refer to so-called before-and-after photos. Considering that treatment results vary depending on the patient's condition, photos that may cause misunderstanding are not permitted as medical advertisements.
However, this does not apply to before-and-after photos that include detailed explanations of the required treatment, costs, main risks, and side effects. Furthermore, the information should be provided in an easily understandable manner, avoiding formats such as links to another page or displaying in extremely small text compared to information about benefits.